These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1819700)
21. Comparison of a radioimmunoassay and bioassay for embryo-derived platelet-activating factor. Ammit AJ; O'Neill C Hum Reprod; 1991 Jul; 6(6):872-8. PubMed ID: 1757528 [TBL] [Abstract][Full Text] [Related]
22. Effect of structural analogues of PAF-acether on platelet desensitization. Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590 [TBL] [Abstract][Full Text] [Related]
23. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain. Tiberghien C; Laurent L; Junier MP; Dray F J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages. Stewart AG; Grigoriadis G J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547 [TBL] [Abstract][Full Text] [Related]
25. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro. Ostermann G; Hofmann B; Kertscher HP; Till U J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804 [TBL] [Abstract][Full Text] [Related]
26. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
27. Stability of platelet activating factor (PAF) in human saliva. Quantitation by radioimmunoassay. Cooney SJ; Smal MA; Baldo BA Clin Chim Acta; 1991 Aug; 200(2-3):161-73. PubMed ID: 1777966 [TBL] [Abstract][Full Text] [Related]
28. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI; Muzya GI Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178 [TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient. Horii T; Okazaki H; Kino M; Kobayashi Y; Satouchi K; Saito K Lipids; 1991 Dec; 26(12):1292-6. PubMed ID: 1819719 [TBL] [Abstract][Full Text] [Related]
31. Species differences in platelet aggregation induced by platelet-activating factor (PAF). Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Ou M; Mori T Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):663-5. PubMed ID: 1294855 [TBL] [Abstract][Full Text] [Related]
32. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. Tokumura A; Yoshida J; Okasaka N; Fukuzawa K; Tsukatani H Thromb Res; 1987 Apr; 46(1):153-61. PubMed ID: 3590110 [TBL] [Abstract][Full Text] [Related]
33. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. Musch MW; Billah MM; Siegel MI Biochem Biophys Res Commun; 1987 May; 144(3):1243-50. PubMed ID: 3107564 [TBL] [Abstract][Full Text] [Related]
35. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). Steiner M; Landolfi R; Motola NC; Turcotte JG Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503 [TBL] [Abstract][Full Text] [Related]
36. Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor. Wissner A; Carroll ML; Green KE; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Wrenn S; Kohler CA J Med Chem; 1992 May; 35(9):1650-62. PubMed ID: 1578493 [TBL] [Abstract][Full Text] [Related]
37. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Tahraoui L; Floch A; Mondot S; Cavero I Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653 [TBL] [Abstract][Full Text] [Related]
38. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation]. Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936 [No Abstract] [Full Text] [Related]
39. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
40. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. Ostermann G; Till U; Thielmann K Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]